ID: ALA4562257

Max Phase: Preclinical

Molecular Formula: C21H13NO4

Molecular Weight: 343.34

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=c1cc(/C=C/c2ccc([N+](=O)[O-])cc2)c2ccc3ccccc3c2o1

Standard InChI:  InChI=1S/C21H13NO4/c23-20-13-16(8-5-14-6-10-17(11-7-14)22(24)25)19-12-9-15-3-1-2-4-18(15)21(19)26-20/h1-13H/b8-5+

Standard InChI Key:  QFCRAGHZOYALQF-VMPITWQZSA-N

Associated Targets(Human)

DNA ligase 1 262 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 343.34Molecular Weight (Monoisotopic): 343.0845AlogP: 5.02#Rotatable Bonds: 3
Polar Surface Area: 73.35Molecular Species: HBA: 4HBD: 0
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.76CX LogD: 4.76
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.23Np Likeness Score: -0.11

References

1. Saquib M, Ansari MI, Johnson CR, Khatoon S, Kamil Hussain M, Coop A..  (2019)  Recent advances in the targeting of human DNA ligase I as a potential new strategy for cancer treatment.,  182  [PMID:31499361] [10.1016/j.ejmech.2019.111657]

Source